Immunomodulatory effect of inhaled kinase inhibitor peptides in lung
US2019022176A1
Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
EP3268022A2
Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
MX2017008994A
Formulation of mk2 inhibitor peptides.
MX2017006372A
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition.
MX2016011852A
Compositions and methods for preventing or treating chronic lung allograft dysfunction and idiopathic pulmonary fibrosis.
US2015064134A1
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
US2015299264A1
Inhibition of cardiac fibrosis in myocardial infarction
CN105120886A
Compositions and methods for treating cutaneous scarring
BR112013026313A2
compositions and methods for preventing or treating diseases, conditions or processes characterized by abnormal fibroblast proliferation and extracellular matrix deposition
EP2575855A2
Methods for treating or preventing vascular graft failure
KR20110095867A
Polypeptide for treating or preventing adhesions
WO2009123759A2
Therapeutic uses of biocompatible biogel compositions
